Eva Ellebaek

15PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersMechanobiologyMedical biochemistry - proteins and peptides (incl. medical proteomics)Medical mycologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 31, 2026
Five-year survival impact of adjuvant anti-PD-1 therapy in a nationwide cohort of stage III melanoma.

|Apr 29, 2026
Real-World Outcomes of Nivolumab and Ipilimumab in Metastatic Melanoma as Third Line and Beyond.

|Oct 19, 2025
Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF-mutant metastatic melanoma: a real-world propensity score-matched survival analysis.

Yago Garitaonaindia, Shawez Khan, Rasmus Friis

|Feb 03, 2025
18F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanoma.

Tine Gadegaard Hindso, Torben Martinussen, Camilla Wium Bjerrum

|Oct 16, 2024
Impact of Metastatic Pattern on Survival in Patients with Posterior Uveal Melanoma: A Retrospective Cohort Study.

Tine G Hindso, Peter S Jensen, Mette B Sjøl

|Sep 14, 2024
Real-World Cardiotoxicity in Metastatic Melanoma Patients Treated with Encorafenib and Binimetinib.

Sidsel Pedersen, Marc Østergaard Nielsen, Marco Donia

Pageof 3

Frequent Collaborators

12 joint publications

Inge Marie Svane

12 joint publications

Marco Donia

4 joint publications

Christina Ruhlmann

4 joint publications

Henrik Schmidt